Seer, Inc. (SEER) Profit Margin
Seer, Inc. (SEER) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -1075.55% |
| 2022-12-31 | -600.05% |
| 2023-12-31 | -517.84% |
| 2024-12-31 | -611.14% |
| 2025-12-31 | -443.96% |
How SEER compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| VYGR | Voyager Therapeutics Inc. | -296.53% |
| NKTR | Nektar Therapeutics | -297.07% |
| GOSS | Gossamer Bio Inc. | -351.49% |
| KURA | Kura Oncology Inc. | -412.95% |
| OCUL | Ocular Therapeutix Inc. | -511.90% |
These are five companies in the same sector as SEER with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Seer, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("SEER", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SEER | $2.05 | +1.49% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |